logo
Early evidence shows AI scribes reduce burnout, but without financial improvement

Early evidence shows AI scribes reduce burnout, but without financial improvement

Axios27-03-2025

AI-powered medical transcription tools are alleviating clinician burnout but not yet saving practices money or making care more efficient, according to a report from the Peterson Health Technology Institute.
Why it matters: AI scribes that can securely transcribe medical notes for providers have exploded in popularity, attracting hundreds of millions of dollars in investments.
State of play: There are now about 60 companies offering technology that listens to and transcribes a patient appointment using AI.
The promise of so-called ambient scribes to alleviate clinician stress is driving health systems to pilot these tools, the Peterson institute says.
As providers increasingly adopt AI scribes, the institute convened a task force of developers, health systems, investors and academics last year to discuss the outlook for the technology.
What they found: Mass General Brigham found a 40% reduction in reported burnout during a six-week survey pilot of an AI scribe, the institute's report says.
MultiCare, a health system in Washington state, found a 63% reduction in clinician-reported burnout due to AI scribe use.
Anecdotes and survey evidence from other providers also show that AI scribes improve clinician and patient experience.
Yes, but: It's too early to tell if the AI tools are making health providers more efficient. A study of 112 physicians using an ambient scribe at Atrium Health showed that the technology did not reach that goal overall.
Task force members also haven't seen significant financial improvements from their scribe technologies.
"As interest grows beyond a subset of clinicians and costs remain significant, health systems will increasingly need to demonstrate a clear return on investment, particularly at current prices," the report notes.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Academic Publishers Sign AI Deals as Trump Cuts Research Funding
Academic Publishers Sign AI Deals as Trump Cuts Research Funding

Bloomberg

time29 minutes ago

  • Bloomberg

Academic Publishers Sign AI Deals as Trump Cuts Research Funding

Academic publishers are rushing to sign licensing deals with artificial intelligence companies, carving out a new revenue stream as US research funding cuts dim their outlook. Informa Plc 's Taylor & Francis signed a $10 million deal with Microsoft Corp. last year to provide the tech giant access to part of its library to train large language models, or LLMs. Bloomsbury Publishing Plc is looking to 'monetize academic content through AI deals,' it said in its latest set of results, while John Wiley & Sons Inc. announced partnerships with Amazon Web Services and Perplexity earlier this year.

Corrado Garibaldi: The Contrarian Trader Who Profits When Others Panic
Corrado Garibaldi: The Contrarian Trader Who Profits When Others Panic

Time Business News

time34 minutes ago

  • Time Business News

Corrado Garibaldi: The Contrarian Trader Who Profits When Others Panic

In the high-stakes world of Trading Invest Celebrity Italy, where herd mentality often leads to costly mistakes, one investor has built his success on a simple but ruthless principle: When others zig, zag. Corrado Garibaldi—better known in finance circles as Lord Conrad—has carved a reputation as a maverick trader who thrives on going against the grain. His mantra? 'Buy the fear. Sell the euphoria.' The Unconventional Path to Trading Mastery Unlike Wall Street's typical Ivy League-educated financiers, Garibaldi is a self-made trader with no formal finance background. An Italian native, he entered the markets out of necessity, driven by a desire to take control of his financial future. 'I never studied economics or attended business school,' he admits. 'I learned by doing—making mistakes, refining strategies, and realizing that most people lose money because they follow the crowd.' The Contrarian Edge: Why 99.9999% of Traders Are Wrong Garibaldi's core philosophy is rooted in contrarian investing—a strategy that capitalizes on market overreactions. 'When everyone is buying, I'm selling. When panic sets in, I'm buying,' he says. 'The masses are almost always wrong at extremes. That's where the real opportunities lie.' This approach has allowed him to profit from major market swings, whether during the crypto crashes of 2022 or the AI stock frenzy of 2024. Two Sides of the Same Coin: Trader by Day, Investor by Night Garibaldi operates in two distinct modes: As a trader, he's a speed-focused tactician, scalping the Nasdaq and executing swing trades with military precision. As an investor, he's a patient wealth-builder, holding long-term positions in giants like Apple, Microsoft, and Tesla while diversifying into bonds and crypto. His portfolio strategy? 99% long-term holdings, 1% high-octane trading—a balance that maximizes growth while keeping risk in check. The Trader's Mindset: Why Psychology Beats IQ For Garibaldi, trading isn't just about charts—it's about mastering fear and greed. 'Most traders fail because they let emotions drive decisions,' he says. 'The key is to stay mechanical. Follow the plan, not the panic.' He enforces strict rules: ✔ Never risk more than 1% on a single trade ✔ Always use stop-losses ✔ Ignore hype—trade the data, not the narrative 2025 and Beyond: Adapt or Die In an era of AI-driven markets and geopolitical volatility, Garibaldi remains agile—constantly refining strategies and engaging with traders worldwide via social media. 'Markets change. If you're not learning, you're losing,' he warns. Final Word: The Slow Road to Trading Success For aspiring traders, Garibaldi's advice is refreshingly honest: 'This isn't a get-rich-quick game. Consistency beats luck. Small, smart gains compound over time—that's how real wealth is built.' Want to see his strategies in action? Visit Trading Invest Celebrity Italy. TIME BUSINESS NEWS

Fresh blow for London as US buyers mount £5bn raid on stock market
Fresh blow for London as US buyers mount £5bn raid on stock market

Yahoo

time2 hours ago

  • Yahoo

Fresh blow for London as US buyers mount £5bn raid on stock market

Two major British companies are poised to join the exodus from the London stock market after American rivals made multibillion-pound takeover offers for each. On Monday, semiconductor company Alphawave recommended a $2.4bn (£1.8bn) sale to US chip giant Qualcomm while high-tech equipment maker Spectris urged shareholders to back a £4.4bn sale to private equity house Advent International. The deals would mean both companies would cease to be listed in London, dealing a fresh blow to the City just days after Wise, the British financial technology champion, announced it was moving its main listing to New York. Both takeovers will also see the American buyers pay substantially above the share prices that their British targets commanded beforehand, prompting suggestions they may have been undervalued by London investors. Qualcomm's offer is more than 90pc above Alphawave's share price before talks began in April and the Spectris bid is 84pc higher than its stock price on Friday. Charles Hall, head of research at Peel Hunt, said: 'The bids for Spectris and Alphawave show how undervalued UK listed companies are given premiums of 85pc and 96pc respectively.' 'It continues the constant theme of companies leaving the market, with 30 takeovers of scale and just one initial public offering on the London Stock Exchange in 2025.' 'Urgent action is required if we want a healthy UK equity market that supports our listed companies and encourages the next generation of companies to list.' Qualcomm said it was buying Alphawave to aid its expansion into data centres, which are becoming increasingly important in the race to develop artificial intelligence (AI) software. Alphawave is a specialist in technologies that 'drive faster, more reliable data transfer with higher performance and lower power consumption', a joint statement by the companies said. This means its products 'form a part of the core infrastructure enabling next-generation services in a wide array of high growth applications, including data centres, AI, data networking and data storage'. Silicon Valley giants such as OpenAI, Google and Amazon are racing to acquire more data centre capacity to help train their AI programmes. Tony Pialis, the president and chief executive of Alphawave, said: 'Together, we will unlock new opportunities for growth, drive innovation, and create a leading player in AI compute and connectivity solutions. 'For our shareholders, the Alphawave board is pleased that Qualcomm's offer provides an opportunity to realise compelling value for their shares.' Spectris, which is headquartered in London, makes various high tech instruments, including particle measuring systems used in the pharmaceutical industry. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store